A phase I study of CPI-0610, a bromodomain and extra terminal protein (BET) inhibitor in patients with relapsed or refractory lymphoma Meeting Abstract
| Authors: | Blum, K. A.; Abramson, J.; Maris, M.; Flinn, I.; Goy, A.; Mertz, J.; Sims, R.; Garner, F.; Senderowicz, A.; Younes, A. |
| Abstract Title: | A phase I study of CPI-0610, a bromodomain and extra terminal protein (BET) inhibitor in patients with relapsed or refractory lymphoma |
| Meeting Title: | TAT 2018 - International Congress on Targeted Anticancer Therapies |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2018 Mar 5-7 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-03-01 |
| Start Page: | mdy048 |
| Language: | English |
| ACCESSION: | WOS:000427179500117 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy048 |
| Notes: | Meeting Abstract:41O -- Appears on p iii7 of abstract booklet -- Source: Wos |
